Cargando…

Mechanism of megaloblastic anemia combined with hemolysis

Megaloblastic anemia (MA) patients often exhibit hemolysis, but it is not clear whether there are other hemolytic mechanisms in addition to intramedullary hemolysis. We retrospectively analyzed the clinical characteristics of 124 MA patients, measured erythrocyte physical parameters in two patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Qiong, Liu, Junru, Xu, Xiaoxuan, Huang, Beihui, Zheng, Dong, Li, Juan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806812/
https://www.ncbi.nlm.nih.gov/pubmed/34542005
http://dx.doi.org/10.1080/21655979.2021.1952366
_version_ 1784643545415548928
author Wu, Qiong
Liu, Junru
Xu, Xiaoxuan
Huang, Beihui
Zheng, Dong
Li, Juan
author_facet Wu, Qiong
Liu, Junru
Xu, Xiaoxuan
Huang, Beihui
Zheng, Dong
Li, Juan
author_sort Wu, Qiong
collection PubMed
description Megaloblastic anemia (MA) patients often exhibit hemolysis, but it is not clear whether there are other hemolytic mechanisms in addition to intramedullary hemolysis. We retrospectively analyzed the clinical characteristics of 124 MA patients, measured erythrocyte physical parameters in two patients with hemolysis and one healthy volunteer by atomic force microscopy, and measured 18F-FDG uptake in one MA patient with hemolysis. In multivariate analysis, hemolysis was associated with mean corpuscular volume (MCV) and indirect bilirubin. A receiver operating characteristic curve analysis, with sensitivity of 83.1% and specificity of 68.7%, suggested that the MCV cutoff value that predicts hemolysis is 116.4 fL. Hb was negatively correlated with MCV in the hemolysis group (r = −0.317, P = 0.007) but not in the nonhemolysis group. The erythrocyte peak-valley value, average cell surface roughness and surface area in the MA patients with hemolysis were significantly lower than those in controls (P < 0.05). 18F-FDG uptake by the liver and spleen was diffuse and increased in MA patients undergoing hemolysis. MA combined with extramedullary hemolysis could be caused by macrophages removing mechanically damaged erythrocytes and the retention of erythrocytes with decreased deformability when blood circulates through narrow spaces in the liver and spleen.
format Online
Article
Text
id pubmed-8806812
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-88068122022-02-02 Mechanism of megaloblastic anemia combined with hemolysis Wu, Qiong Liu, Junru Xu, Xiaoxuan Huang, Beihui Zheng, Dong Li, Juan Bioengineered Research Paper Megaloblastic anemia (MA) patients often exhibit hemolysis, but it is not clear whether there are other hemolytic mechanisms in addition to intramedullary hemolysis. We retrospectively analyzed the clinical characteristics of 124 MA patients, measured erythrocyte physical parameters in two patients with hemolysis and one healthy volunteer by atomic force microscopy, and measured 18F-FDG uptake in one MA patient with hemolysis. In multivariate analysis, hemolysis was associated with mean corpuscular volume (MCV) and indirect bilirubin. A receiver operating characteristic curve analysis, with sensitivity of 83.1% and specificity of 68.7%, suggested that the MCV cutoff value that predicts hemolysis is 116.4 fL. Hb was negatively correlated with MCV in the hemolysis group (r = −0.317, P = 0.007) but not in the nonhemolysis group. The erythrocyte peak-valley value, average cell surface roughness and surface area in the MA patients with hemolysis were significantly lower than those in controls (P < 0.05). 18F-FDG uptake by the liver and spleen was diffuse and increased in MA patients undergoing hemolysis. MA combined with extramedullary hemolysis could be caused by macrophages removing mechanically damaged erythrocytes and the retention of erythrocytes with decreased deformability when blood circulates through narrow spaces in the liver and spleen. Taylor & Francis 2021-09-19 /pmc/articles/PMC8806812/ /pubmed/34542005 http://dx.doi.org/10.1080/21655979.2021.1952366 Text en © 2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Wu, Qiong
Liu, Junru
Xu, Xiaoxuan
Huang, Beihui
Zheng, Dong
Li, Juan
Mechanism of megaloblastic anemia combined with hemolysis
title Mechanism of megaloblastic anemia combined with hemolysis
title_full Mechanism of megaloblastic anemia combined with hemolysis
title_fullStr Mechanism of megaloblastic anemia combined with hemolysis
title_full_unstemmed Mechanism of megaloblastic anemia combined with hemolysis
title_short Mechanism of megaloblastic anemia combined with hemolysis
title_sort mechanism of megaloblastic anemia combined with hemolysis
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806812/
https://www.ncbi.nlm.nih.gov/pubmed/34542005
http://dx.doi.org/10.1080/21655979.2021.1952366
work_keys_str_mv AT wuqiong mechanismofmegaloblasticanemiacombinedwithhemolysis
AT liujunru mechanismofmegaloblasticanemiacombinedwithhemolysis
AT xuxiaoxuan mechanismofmegaloblasticanemiacombinedwithhemolysis
AT huangbeihui mechanismofmegaloblasticanemiacombinedwithhemolysis
AT zhengdong mechanismofmegaloblasticanemiacombinedwithhemolysis
AT lijuan mechanismofmegaloblasticanemiacombinedwithhemolysis